These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29652138)

  • 1. Development of a Selective Labeling Probe for Bruton's Tyrosine Kinase Quantification in Live Cells.
    Chen J; Wang X; He F; Pan Z
    Bioconjug Chem; 2018 May; 29(5):1640-1645. PubMed ID: 29652138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel reactive turn-on probe capable of selective profiling and no-wash imaging of Bruton's tyrosine kinase in live cells.
    Wang X; Ma N; Wu R; Ding K; Li Z
    Chem Commun (Camb); 2019 Mar; 55(24):3473-3476. PubMed ID: 30829351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Turn On/Off' fluorescence probe for the screening of unactivated Bruton's tyrosine kinase.
    Kawahata W; Asami T; Fujii I; Sawa M
    Bioorg Med Chem Lett; 2015; 25(10):2141-5. PubMed ID: 25843639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton's Tyrosine Kinase.
    Lee E; Cho H; Lee DK; Ha J; Choi BJ; Jeong JH; Ryu JH; Kang JS; Jeon R
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.
    Kong W; Deng W; Sun Y; Huang S; Zhang Z; Shi B; Chen W; Tang X; Yao G; Feng X; Sun L
    Clin Rheumatol; 2018 Jan; 37(1):43-49. PubMed ID: 28612243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton's Tyrosine Kinase Is Not Essential for B Cell Survival beyond Early Developmental Stages.
    Nyhoff LE; Clark ES; Barron BL; Bonami RH; Khan WN; Kendall PL
    J Immunol; 2018 Apr; 200(7):2352-2361. PubMed ID: 29483358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors.
    Koraboina CP; Maddipati VC; Annadurai N; Gurská S; Džubák P; Hajdúch M; Das V; Gundla R
    ChemMedChem; 2024 Jan; 19(1):e202300511. PubMed ID: 37916435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's tyrosine kinase: potential target in human multiple myeloma.
    Liu Y; Dong Y; Jiang QL; Zhang B; Hu AM
    Leuk Lymphoma; 2014 Jan; 55(1):177-81. PubMed ID: 23581641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TR-FRET binding assay targeting unactivated form of Bruton's tyrosine kinase.
    Asami T; Kawahata W; Sawa M
    Bioorg Med Chem Lett; 2015; 25(10):2033-6. PubMed ID: 25872980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bruton's tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018).
    Feng Y; Duan W; Cu X; Liang C; Xin M
    Expert Opin Ther Pat; 2019 Apr; 29(4):217-241. PubMed ID: 30888232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens.
    Hopkins BT; Bame E; Bell N; Bohnert T; Bowden-Verhoek JK; Bui M; Cancilla MT; Conlon P; Cullen P; Erlanson DA; Fan J; Fuchs-Knotts T; Hansen S; Heumann S; Jenkins TJ; Marcotte D; McDowell B; Mertsching E; Negrou E; Otipoby KL; Poreci U; Romanowski MJ; Scott D; Silvian L; Yang W; Zhong M
    Bioorg Med Chem; 2019 Jul; 27(13):2905-2913. PubMed ID: 31138459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation.
    Goess C; Harris CM; Murdock S; McCarthy RW; Sampson E; Twomey R; Mathieu S; Mario R; Perham M; Goedken ER; Long AJ
    Mod Rheumatol; 2019 May; 29(3):510-522. PubMed ID: 29862859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton's Tyrosine Kinase for the Treatment of Lymphoma.
    Zhang J; Che J; Luo X; Wu M; Kan W; Jin Y; Wang H; Pang A; Li C; Huang W; Zeng S; Zhuang W; Wu Y; Xu Y; Zhou Y; Li J; Dong X
    J Med Chem; 2022 Jul; 65(13):9096-9125. PubMed ID: 35671249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Skaddan MB; Wooten DW; Wilcox KC; Voorbach MJ; Reuter DR; Jia ZJ; Foster-Duke KD; Hickson JA; Vaidyanathan S; Reed AD; Tovcimak AE; Guo Q; Comley RA; Lee L; Finnema SJ; Mudd SR
    Mol Imaging Biol; 2022 Oct; 24(5):830-841. PubMed ID: 35482146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 4,7-Diamino-5-(4-phenoxyphenyl)-6-methylene-pyrimido[5,4- b]pyrrolizines as Novel Bruton's Tyrosine Kinase Inhibitors.
    Xue Y; Song P; Song Z; Wang A; Tong L; Geng M; Ding J; Liu Q; Sun L; Xie H; Zhang A
    J Med Chem; 2018 May; 61(10):4608-4627. PubMed ID: 29715023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
    Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
    Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton's Tyrosine Kinase Inhibitor.
    Lee KW; Lee WH; Han BS; Lee JH; Doo EK; Kim JH
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357562
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity.
    Rip J; Van Der Ploeg EK; Hendriks RW; Corneth OBJ
    Crit Rev Immunol; 2018; 38(1):17-62. PubMed ID: 29717662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanism for Bruton's tyrosine kinase activation at the cell membrane.
    Wang Q; Pechersky Y; Sagawa S; Pan AC; Shaw DE
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9390-9399. PubMed ID: 31019091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.